Ausbil Investment Management Ltd Raises Stock Position in National Health Investors, Inc. $NHI

Ausbil Investment Management Ltd lifted its position in National Health Investors, Inc. (NYSE:NHI) by 152.9% in the third quarter, Holdings Channel reports. The firm owned 12,850 shares of the real estate investment trust’s stock after buying an additional 7,769 shares during the period. Ausbil Investment Management Ltd’s holdings in National Health Investors were worth $1,026,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its holdings in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares during the period. Smartleaf Asset Management LLC grew its position in shares of National Health Investors by 49.8% during the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock worth $33,000 after buying an additional 147 shares in the last quarter. Assetmark Inc. increased its stake in shares of National Health Investors by 19.0% during the second quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock valued at $65,000 after buying an additional 148 shares during the period. NewEdge Advisors LLC raised its holdings in shares of National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares in the last quarter. Finally, Osaic Holdings Inc. grew its holdings in National Health Investors by 24.1% during the 2nd quarter. Osaic Holdings Inc. now owns 1,629 shares of the real estate investment trust’s stock worth $115,000 after acquiring an additional 316 shares in the last quarter. Institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Performance

NHI opened at $78.56 on Friday. The company has a market cap of $3.74 billion, a P/E ratio of 24.78, a price-to-earnings-growth ratio of 3.00 and a beta of 0.68. The company has a quick ratio of 10.64, a current ratio of 10.64 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $76.69 and its 200-day moving average price is $75.06. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $80.56.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The business had revenue of $83.36 million for the quarter, compared to analyst estimates of $85.66 million. During the same quarter in the prior year, the business posted $1.03 EPS. National Health Investors’s revenue for the quarter was down 1.8% compared to the same quarter last year. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, equities analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.7%. National Health Investors’s payout ratio is 116.09%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on NHI shares. Truist Financial boosted their price target on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a report on Monday. KeyCorp lifted their price target on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research report on Tuesday. Cantor Fitzgerald started coverage on National Health Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $90.00 price objective on the stock. Finally, National Bankshares set a $90.00 target price on shares of National Health Investors in a report on Wednesday, October 1st. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, National Health Investors currently has an average rating of “Buy” and a consensus price target of $87.33.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.